Our previous study has confirmed that pharmacologic activation of the cGMP/PKG2 signaling by cinaciguat could improve implant osseointegration in T2DM rats [9], but its effects on osteoblast biological behavior on titanium surface in vitro remain unclear. Here, PRKG2 is linked to type 2 diabetes mellitus.